Radius Health, Inc. (NASDAQ:RDUS) has market worth of 1.58B along 47.57M outstanding shares. The stock moved -3.10% to $32.24 in recent session. The recent traded volume is 601677 shares. The stock is now at $33.27. The stock has recorded a weekly performance of -2.15% and monthly performance is -5.67%. Shares have moved -12.49% over the last quarter and changed -3.84% over the recent six months. The shares registered yearly performance at -12.70% and YTD move seen at 4.72%.
Many Insiders have done trades inside the company. The Company has disclosed insider trading transaction to the Securities and Exchange Commission (SEC). The BIOTECH GROWTH N V; 10% Owner of Radius Health, Inc. acquired 40000 shares at value of $33.8 on 19 Apr 2018. The Insider selling transaction had a total value worth of $1351936. After the buying activity, now BIOTECH GROWTH N V directly owns 6050913 shares of the company’s stock, valued at approximately $195081435.12. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing on 23 Apr 2018.
Radius Health, Inc.’s insider BIOTECH GROWTH N V purchased 50000 shares of the stock in a negotiation that occurred on 05 Apr 2018. The stock was bought at an average cost of S 36.58 per share, for a total transaction worth of $ 1828845. The Buy was disclosed in a legal filing with the Securities & Exchange Commission, on 09 Apr 2018.
In related news, BIOTECH GROWTH N V 10% Owner bought 80000 shares of the firm’s stock in a transaction that recorded on 02 Mar 2018. The stock was bought at an average price of $ 32.52 for a total value of $ 2601448. After the negotiation, now Insider holds 5853799 shares of the company’s stock, valued at approximately $ 188726479.76.
BIOTECH GROWTH N V 10% Owner at Radius Health, Inc. also bought 75000 on 09 Feb 2018 at an average price of $ 34.38 for a total value of $ 2578763. After the transaction, BIOTECH GROWTH N V owns 5773799 shares of the company’s stock, now priced at approximately $ 186147279.76. . The disclosure for this transaction can be found in SEC Form 4 submitted on 12 Feb 2018.
The stock made income -254.20M on sales of 22.10M. ROA sticks to -67.60%. Shares have moved -34.42% from its 1 Year high price and changed 30.74% from its 1 Year low price. The shares registered RSI (14) at 34.07 and ATR factor was seen at 1.56.
In terms of profitability, Radius Health, Inc. has a gross margin of 94.00%. Return on assets come to -67.60% and return on investment coming to -61.00% while Return on equity come to -100.00%.